Brian Hubbard has over 20 years of experience in the biopharmaceutical industry. He has directed research and development efforts at Millenium Pharmaceuticals, Novartis, and Merck, and built an industry-facing group at the Broad Institute. He has a proven track record of delivering therapies to the clinic and has founded over 10 biotechnology companies. Brian is a founding partner of Sprout BioVentures and currently serves as CEO for Dogma Therapeutics, Flash Therapeutics, and Anji Pharma.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)